Placebo News and Research

RSS

Daily supplementation with vitamin D and fish oil may lower the risk of autoimmune disease

Taking daily vitamin D supplements - or a combination of vitamin D and omega-3 fish oil - appears to carry a lower risk of developing autoimmune disease, with a more pronounced effect after two years, finds a trial of older US adults published by The BMJ today.

27 Jan 2022

Study explores how cannabis use affects driving performance

The steady rise in the use of cannabis - 18 states have legalized recreational use, 13 have decriminalized its use and 36 have medical cannabis laws - has provoked myriad questions and concerns about public health implications, including how cannabis may affect the abilities, real and perceived, of drivers under the influence.

26 Jan 2022

Does remdesivir reduce mortality in moderately ill hospitalized patients with COVID-19?

A team of researchers performed a meta-analysis to investigate the use of remdesivir in the treatment of COVID-19.

26 Jan 2022

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Transfusions of blood plasma donated by people who have recovered from COVID-19 may help patients hospitalized with the virus, a new international study shows.

25 Jan 2022

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

In a new study, a team of researchers reviewed the published literature to find evidence for humoral SARS-CoV-2 correlate of protection (CoP).

25 Jan 2022

Causal impact of spontaneous relaxation of social distancing practices on spread of SARS-CoV-2 in US

The purpose of a recent study was to examine the causal impact of a spontaneous relaxation of social distancing measures on the spread of SARS-CoV-2.

24 Jan 2022

Study examines how elimination of race-based adjustments in kidney function estimates impacts clinical trials

Considerable controversy surrounds race-based algorithms in medicine - such as an adjustment for Black race in equations that estimate individuals' kidney function. A new study in CJASN has examined the impact of changes to these equations on the inclusion of Black participants in kidney disease–related clinical trials, and on the results of such trials.

24 Jan 2022

Echinacea as a potential force against coronavirus infections

A new review identified clinical studies evaluating coronavirus infections in the context of Echinacea administration and assessed preventive and therapy advantages against COVID-19.

21 Jan 2022

New opportunity to induce remission of peanut allergy in young children through oral immunotherapy

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5 years.

21 Jan 2022

Oral supplement appears to promote muscle endurance and mitochondrial health in humans

An oral supplement intended to stimulate a natural body process appears to promote muscle endurance and mitochondrial health in humans.

20 Jan 2022

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in The Lancet.

20 Jan 2022

Researchers compare two psychotherapies used for treating veterans with PTSD

Cognitive processing therapy and prolonged exposure are the two leading trauma-focused cognitive behavioral psychotherapies used for Veterans Affairs patients with PTSD.

20 Jan 2022

"Nocebo effect" accounts for 76% of all adverse events in the COVID-19 vaccine trial group

The placebo effect is the well-known phenomenon of a person's physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit – a sugar pill, or a syringe full of saline, for example.

18 Jan 2022

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Researchers prevent evidence on the efficacy of neutralizing monoclonal antibodies in treating COVID-19.

17 Jan 2022

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Researchers investigate the efficacy of hydroxychloroquine and chloroquine in the treatment of patients hospitalized with COVID-19.

17 Jan 2022

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

A recent study revealed the effectiveness of 93% for the BNT162b2 vaccine against COVID-19 hospitalization among adolescents (12 to 18 years). This study included 179 patients at 19 sites in 16 states. The same group of researchers have extended their analysis to 31 locations in 23 states across the U.S. and recruited 266 more patients who had been hospitalized with SARS-CoV-2 infection.

13 Jan 2022

Ketamine plus psychological therapy can help people stay off alcohol for longer time

People with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low doses of ketamine combined with psychological therapy in a clinical trial.

11 Jan 2022

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

A new study shows how a daily use of Lactobacillus rhamnosus GG (LGG) probiotic may protect against symptom development in instances when it is used as post-exposure prophylaxis within seven days after exposure to severe acute respiratory syndrome coronavirus 2.

7 Jan 2022

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced the first participant has been dosed in the Phase 1 study of mRNA-1189, the Company's Epstein-Barr Virus vaccine candidate.

7 Jan 2022

FIND trial: Higher vitamin D intake does not affect mortality or cardiovascular disease, cancer risk

A trial by the University of Eastern Finland found that taking a much higher dose of vitamin D than recommended for five years did not affect total mortality or the incidence of cardiovascular disease or cancer in older men and women.

7 Jan 2022

Placebo News and Research

Daily supplementation with vitamin D and fish oil may lower the risk of autoimmune disease

Study explores how cannabis use affects driving performance

Does remdesivir reduce mortality in moderately ill hospitalized patients with COVID-19?

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

Causal impact of spontaneous relaxation of social distancing practices on spread of SARS-CoV-2 in US

Study examines how elimination of race-based adjustments in kidney function estimates impacts clinical trials

Echinacea as a potential force against coronavirus infections

New opportunity to induce remission of peanut allergy in young children through oral immunotherapy

Oral supplement appears to promote muscle endurance and mitochondrial health in humans

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

Researchers compare two psychotherapies used for treating veterans with PTSD

"Nocebo effect" accounts for 76% of all adverse events in the COVID-19 vaccine trial group

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

Ketamine plus psychological therapy can help people stay off alcohol for longer time

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

FIND trial: Higher vitamin D intake does not affect mortality or cardiovascular disease, cancer risk

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News